Edwards Lifesciences Corp (EW)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 5,439,500 | 6,004,800 | 5,382,400 | 5,232,500 | 4,386,300 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $5,439,500K ÷ $—K
= —
Based on the provided data, it appears that there is no specific information available regarding Edwards Lifesciences Corp's receivables turnover for the years 2020 to 2024. Without this key metric, it is challenging to assess the effectiveness of the company in collecting outstanding receivables and managing its credit terms. Receivables turnover is a critical indicator of a company's efficiency in converting credit sales into cash, reflecting its liquidity and operational performance. It would be advisable for investors and stakeholders to seek additional information or financial statements to evaluate Edwards Lifesciences Corp's receivables turnover and its implications for the company's financial health and management of accounts receivable.
Peer comparison
Dec 31, 2024